{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:40:16Z","timestamp":1792518016003,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370529"],"award-info":[{"award-number":["82370529"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303391"],"award-info":[{"award-number":["82303391"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Science and Technology Program key projects","doi-asserted-by":"publisher","award":["2024B03J0466"],"award-info":[{"award-number":["2024B03J0466"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Science and Technology Program key projects","doi-asserted-by":"publisher","award":["2023A04J0581"],"award-info":[{"award-number":["2023A04J0581"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003785","name":"Guangdong Medical Research Foundation","doi-asserted-by":"publisher","award":["2022A1515111193"],"award-info":[{"award-number":["2022A1515111193"]}],"id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"DOI":"10.1038\/s41416-026-03636-2","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T14:02:12Z","timestamp":1792245732000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CXCL14+ fibroblasts promote development of IBD-associated fibrosis and cancer by interacting with SPP1+ macrophages via collagen IV secretion"],"prefix":"10.1038","author":[{"given":"Haonan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiusan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifeng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanxiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2115-5928","authenticated-orcid":false,"given":"Mingsong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,17]]},"reference":[{"key":"3636_CR1","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.gtc.2022.05.003","volume":"51","author":"AS Faye","year":"2022","unstructured":"Faye AS, Holmer AK, Axelrad JE. Cancer in inflammatory bowel disease. Gastroenterol Clin North Am. 2022;51:649\u201366.","journal-title":"Gastroenterol Clin North Am"},{"key":"3636_CR2","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1002\/ueg2.12330","volume":"10","author":"I Al Bakir","year":"2022","unstructured":"Al Bakir I, Kabir M, Yalchin M, Hart A. Optimising inflammatory bowel disease surveillance and dysplasia management-Where do we stand? U Eur Gastroenterol J. 2022;10:1054\u201362.","journal-title":"U Eur Gastroenterol J"},{"key":"3636_CR3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1136\/gutjnl-2020-320945","volume":"70","author":"JE Axelrad","year":"2021","unstructured":"Axelrad JE, Ol\u00e9n O, Sachs MC, Erichsen R, Pedersen L, Halfvarson J, et al. Inflammatory bowel disease and risk of small bowel cancer: a binational population-based cohort study from Denmark and Sweden. Gut. 2021;70:297\u2013308.","journal-title":"Gut"},{"key":"3636_CR4","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1053\/j.gastro.2022.05.038","volume":"163","author":"D Piovani","year":"2022","unstructured":"Piovani D, Hassan C, Repici A, Rimassa L, Carlo-Stella C, Nikolopoulos GK, et al. Risk of cancer in inflammatory bowel diseases: umbrella review and reanalysis of meta-analyses. Gastroenterology. 2022;163:671\u201384.","journal-title":"Gastroenterology"},{"key":"3636_CR5","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.cgh.2013.03.034","volume":"12","author":"MD Kappelman","year":"2014","unstructured":"Kappelman MD, Farkas DK, Long MD, Erichsen R, Sandler RS, S\u00f8rensen HT, et al. Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation. Clin Gastroenterol Hepatol. 2014;12:265\u201373.e1.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3636_CR6","doi-asserted-by":"publisher","first-page":"e319","DOI":"10.1097\/SLA.0000000000005339","volume":"276","author":"C Lu","year":"2022","unstructured":"Lu C, Schardey J, Zhang T, Crispin A, Wirth U, Karcz KW, et al. Survival outcomes and clinicopathological features in inflammatory bowel disease-associated colorectal cancer: a systematic review and meta-analysis. Ann Surg. 2022;276:e319\u2013e30.","journal-title":"Ann Surg"},{"key":"3636_CR7","doi-asserted-by":"publisher","first-page":"431","DOI":"10.15403\/jgld.2014.1121.254.nis","volume":"25","author":"LH Nissen","year":"2016","unstructured":"Nissen LH, Assendorp EL, van der Post RS, Derikx LA, de Jong DJ, Kievit W, et al. Impaired gastric cancer survival in patients with inflammatory bowel disease. J Gastrointestin Liver Dis. 2016;25:431\u201340.","journal-title":"J Gastrointestin Liver Dis"},{"key":"3636_CR8","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1053\/j.gastro.2023.07.014","volume":"165","author":"PK Mukherjee","year":"2023","unstructured":"Mukherjee PK, Nguyen QT, Li J, Zhao S, Christensen SM, West GA, et al. Stricturing Crohn\u2019s disease single-cell RNA sequencing reveals fibroblast heterogeneity and intercellular interactions. Gastroenterology. 2023;165:1180\u201396.","journal-title":"Gastroenterology"},{"key":"3636_CR9","doi-asserted-by":"publisher","first-page":"13372","DOI":"10.1002\/jcb.28612","volume":"120","author":"L Li","year":"2019","unstructured":"Li L, Li Q, Wei L, Wang Z, Ma W, Liu F, et al. Chemokine (C-X-C motif) ligand 14 contributes to lipopolysaccharide-induced fibrogenesis in mouse L929 fibroblasts via modulating PPM1A. J Cell Biochem. 2019;120:13372\u201381.","journal-title":"J Cell Biochem"},{"key":"3636_CR10","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/s12276-023-01013-0","volume":"55","author":"D Yang","year":"2023","unstructured":"Yang D, Liu J, Qian H, Zhuang Q. Cancer-associated fibroblasts: from basic science to anticancer therapy. Exp Mol Med. 2023;55:1322\u201332.","journal-title":"Exp Mol Med"},{"key":"3636_CR11","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1093\/ndt\/gfaa301","volume":"37","author":"L Landolt","year":"2022","unstructured":"Landolt L, Spagnoli GC, Hertig A, Brocheriou I, Marti HP. Fibrosis and cancer: shared features and mechanisms suggest common targeted therapeutic approaches. Nephrol Dial Transpl. 2022;37:1024\u201332.","journal-title":"Nephrol Dial Transpl"},{"key":"3636_CR12","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1136\/gutjnl-2023-329963","volume":"73","author":"F Rieder","year":"2024","unstructured":"Rieder F, Mukherjee PK, Massey WJ, Wang Y, Fiocchi C. Fibrosis in IBD: from pathogenesis to therapeutic targets. Gut. 2024;73:854\u201366.","journal-title":"Gut"},{"key":"3636_CR13","doi-asserted-by":"publisher","first-page":"601","DOI":"10.5009\/gnl19229","volume":"14","author":"W Xu","year":"2020","unstructured":"Xu W, Ding W, Gu Y, Cui L, Zhong J, Du P. Risk factors of colorectal stricture associated with developing high-grade dysplasia or cancer in ulcerative colitis: a multicenter long-term follow-up study. Gut Liver. 2020;14:601\u201310.","journal-title":"Gut Liver"},{"key":"3636_CR14","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1136\/gut.33.7.938","volume":"33","author":"V Gumaste","year":"1992","unstructured":"Gumaste V, Sachar DB, Greenstein AJ. Benign and malignant colorectal strictures in ulcerative colitis. Gut. 1992;33:938\u201341.","journal-title":"Gut"},{"key":"3636_CR15","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adk8805","volume":"10","author":"AM Xu","year":"2024","unstructured":"Xu AM, Haro M, Walts AE, Hu Y, John J, Karlan BY, et al. Spatiotemporal architecture of immune cells and cancer-associated fibroblasts in high-grade serous ovarian carcinoma. Sci Adv. 2024;10:eadk8805.","journal-title":"Sci Adv"},{"key":"3636_CR16","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nrm3904","volume":"15","author":"C Bonnans","year":"2014","unstructured":"Bonnans C, Chou J, Werb Z. Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol. 2014;15:786\u2013801.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3636_CR17","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.1242\/jcs.023820","volume":"123","author":"C Frantz","year":"2010","unstructured":"Frantz C, Stewart KM, Weaver VM. The extracellular matrix at a glance. J Cell Sci. 2010;123:4195\u2013200.","journal-title":"J Cell Sci"},{"key":"3636_CR18","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1038\/onc.2011.89","volume":"30","author":"JV Burnier","year":"2011","unstructured":"Burnier JV, Wang N, Michel RP, Hassanain M, Li S, Lu Y, et al. Type IV collagen-initiated signals provide survival and growth cues required for liver metastasis. Oncogene. 2011;30:3766\u201383.","journal-title":"Oncogene"},{"key":"3636_CR19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.matbio.2023.04.002","volume":"119","author":"A Naik","year":"2023","unstructured":"Naik A, Leask A. Tumor-associated fibrosis impairs the response to immunotherapy. Matrix Biol. 2023;119:125\u201340.","journal-title":"Matrix Biol"},{"key":"3636_CR20","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ccell.2023.12.021","volume":"42","author":"L Cords","year":"2024","unstructured":"Cords L, Engler S, Haberecker M, R\u00fcschoff JH, Moch H, de Souza N, et al. Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer. Cancer Cell. 2024;42:396\u2013412.e5.","journal-title":"Cancer Cell"},{"key":"3636_CR21","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1126\/science.ade2292","volume":"381","author":"R Bill","year":"2023","unstructured":"Bill R, Wirapati P, Messemaker M, Roh W, Zitti B, Duval F, et al. CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers. Science. 2023;381:515\u201324.","journal-title":"Science"},{"key":"3636_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03773-0","volume":"9","author":"CM Wunderlich","year":"2018","unstructured":"Wunderlich CM, Ackermann PJ, Ostermann AL, Adams-Quack P, Vogt MC, Tran ML, et al. Obesity exacerbates colitis-associated cancer via IL-6-regulated macrophage polarisation and CCL-20\/CCR-6-mediated lymphocyte recruitment. Nat Commun. 2018;9:1646.","journal-title":"Nat Commun"},{"key":"3636_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29366-6","volume":"13","author":"J Qi","year":"2022","unstructured":"Qi J, Sun H, Zhang Y, Wang Z, Xun Z, Li Z, et al. Single-cell and spatial analysis reveal interaction of FAP(+) fibroblasts and SPP1(+) macrophages in colorectal cancer. Nat Commun. 2022;13:1742.","journal-title":"Nat Commun"},{"key":"3636_CR24","doi-asserted-by":"crossref","unstructured":"Heichler C, Schmied A, Enderle K, Scheibe K, Murawska M, Schmid B, et al. Targeting STAT3 Signaling in COL1+ Fibroblasts Controls Colitis-Associated Cancer in Mice. Cancers. 2022;14.","DOI":"10.3390\/cancers14061472"},{"key":"3636_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e28332","volume":"10","author":"M Rakina","year":"2024","unstructured":"Rakina M, Larionova I, Kzhyshkowska J. Macrophage diversity in human cancers: New insight provided by single-cell resolution and spatial context. Heliyon. 2024;10:e28332.","journal-title":"Heliyon"},{"key":"3636_CR26","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1158\/0008-5472.CAN-23-1448","volume":"84","author":"C Li","year":"2024","unstructured":"Li C, Guo H, Zhai P, Yan M, Liu C, Wang X, et al. Spatial and single-cell transcriptomics reveal a cancer-associated fibroblast subset in HNSCC that restricts infiltration and antitumor activity of CD8+ T Cells. Cancer Res. 2024;84:258\u201375.","journal-title":"Cancer Res"},{"key":"3636_CR27","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.ccell.2024.06.009","volume":"42","author":"Y Chen","year":"2024","unstructured":"Chen Y, Wang D, Li Y, Qi L, Si W, Bo Y, et al. Spatiotemporal single-cell analysis decodes cellular dynamics underlying different responses to immunotherapy in colorectal cancer. Cancer Cell. 2024;42:1268\u201385.e7.","journal-title":"Cancer Cell"},{"key":"3636_CR28","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1053\/j.gastro.2021.10.035","volume":"162","author":"SC Shah","year":"2022","unstructured":"Shah SC, Itzkowitz SH. Colorectal cancer in inflammatory bowel disease: mechanisms and management. Gastroenterology. 2022;162:715\u201330.e3.","journal-title":"Gastroenterology"},{"key":"3636_CR29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1021\/acsmedchemlett.9b00382","volume":"11","author":"DE Jeffries","year":"2020","unstructured":"Jeffries DE, Borza CM, Blobaum AL, Pozzi A, Lindsley CW. Discovery of VU6015929: a selective discoidin domain Receptor 1\/2 (DDR1\/2) inhibitor to explore the role of DDR1 in antifibrotic therapy. ACS Med Chem Lett. 2020;11:29\u201333.","journal-title":"ACS Med Chem Lett"},{"key":"3636_CR30","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/mc.23637","volume":"63","author":"A Liu","year":"2024","unstructured":"Liu A, Zhang S, Wang M, Zhang L, Xu S, Nasimian A, et al. DDR1\/2 enhance KIT activation and imatinib resistance of primary and secondary KIT mutants in gastrointestinal stromal tumors. Mol Carcinog. 2024;63:75\u201393.","journal-title":"Mol Carcinog"},{"key":"3636_CR31","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.3389\/fmicb.2019.02439","volume":"10","author":"S Millen","year":"2019","unstructured":"Millen S, Gross C, Donhauser N, Mann MC, P\u00e9lopon\u00e8se JM Jr., Thoma-Kress AK. Collagen IV (COL4A1, COL4A2), a component of the viral biofilm, is induced by the HTLV-1 Oncoprotein Tax and impacts virus transmission. Front Microbiol. 2019;10:2439.","journal-title":"Front Microbiol"},{"key":"3636_CR32","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4103\/aam.aam_56_18","volume":"18","author":"N Singh","year":"2019","unstructured":"Singh N, Baby D, Rajguru JP, Patil PB, Thakkannavar SS, Pujari VB. Inflammation and cancer. Ann Afr Med. 2019;18:121\u20136.","journal-title":"Ann Afr Med"},{"key":"3636_CR33","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1056\/NEJMra1403718","volume":"372","author":"L Beaugerie","year":"2015","unstructured":"Beaugerie L, Itzkowitz SH. Cancers complicating inflammatory bowel disease. N Engl J Med. 2015;372:1441\u201352.","journal-title":"N Engl J Med"},{"key":"3636_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-024-01932-2","volume":"29","author":"S Xin","year":"2024","unstructured":"Xin S, Liu X, He C, Gao H, Wang B, Hua R, et al. Inflammation accelerating intestinal fibrosis: from mechanism to clinic. Eur J Med Res. 2024;29:335.","journal-title":"Eur J Med Res"},{"key":"3636_CR35","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s10555-024-10169-8","volume":"43","author":"H Fujimoto","year":"2024","unstructured":"Fujimoto H, Yoshihara M, Rodgers R, Iyoshi S, Mogi K, Miyamoto E, et al. Tumor-associated fibrosis: a unique mechanism promoting ovarian cancer metastasis and peritoneal dissemination. Cancer Metastasis Rev. 2024;43:1037\u201353.","journal-title":"Cancer Metastasis Rev"},{"key":"3636_CR36","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.gtc.2021.12.011","volume":"51","author":"S Friedberg","year":"2022","unstructured":"Friedberg S, Rubin DT. Intestinal Cancer and Dysplasia in Crohn\u2019s disease. Gastroenterol Clin North Am. 2022;51:369\u201379.","journal-title":"Gastroenterol Clin North Am"},{"key":"3636_CR37","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41590-023-01687-8","volume":"25","author":"A Lei","year":"2024","unstructured":"Lei A, Yu H, Lu S, Lu H, Ding X, Tan T, et al. A second-generation M1-polarized CAR macrophage with antitumor efficacy. Nat Immunol. 2024;25:102\u201316.","journal-title":"Nat Immunol"},{"key":"3636_CR38","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","volume":"8","author":"S Chen","year":"2023","unstructured":"Chen S, Saeed A, Liu Q, Jiang Q, Xu H, Xiao GG, et al. Macrophages in immunoregulation and therapeutics. Signal Transduct Target Ther. 2023;8:207.","journal-title":"Signal Transduct Target Ther"},{"key":"3636_CR39","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.3389\/fimmu.2019.01084","volume":"10","author":"M Orecchioni","year":"2019","unstructured":"Orecchioni M, Ghosheh Y, Pramod AB, Ley K. Macrophage Polarization: Different gene signatures in M1(LPS+) vs. classically and M2(LPS-) vs. alternatively activated macrophages. Front Immunol. 2019;10:1084.","journal-title":"Front Immunol"},{"key":"3636_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1338918","volume":"14","author":"H Zhang","year":"2023","unstructured":"Zhang H, Shi Y, Lin C, He C, Wang S, Li Q, et al. Overcoming cancer risk in inflammatory bowel disease: new insights into preventive strategies and pathogenesis mechanisms including interactions of immune cells, cancer signaling pathways, and gut microbiota. Front Immunol. 2023;14:1338918.","journal-title":"Front Immunol"},{"key":"3636_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1545","volume":"14","author":"X Di","year":"2024","unstructured":"Di X, Chen J, Li Y, Wang M, Wei J, Li T, et al. Crosstalk between fibroblasts and immunocytes in fibrosis: From molecular mechanisms to clinical trials. Clin Transl Med. 2024;14:e1545.","journal-title":"Clin Transl Med"},{"key":"3636_CR42","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13046-023-02935-3","volume":"43","author":"W Luo","year":"2024","unstructured":"Luo W, Wen T, Qu X. Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept. J Exp Clin Cancer Res. 2024;43:8.","journal-title":"J Exp Clin Cancer Res"},{"key":"3636_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.188901","volume":"1878","author":"RJ Kehrberg","year":"2023","unstructured":"Kehrberg RJ, Bhyravbhatla N, Batra SK, Kumar S. Epigenetic regulation of cancer-associated fibroblast heterogeneity. Biochim Biophys Acta Rev Cancer. 2023;1878:188901.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"3636_CR44","doi-asserted-by":"publisher","first-page":"4317","DOI":"10.2147\/JIR.S426004","volume":"16","author":"Z Xiong","year":"2023","unstructured":"Xiong Z, Fang Y, Lu S, Sun Q, Huang J. Identification and validation of signature genes and potential therapy targets of inflammatory bowel disease and periodontitis. J Inflamm Res. 2023;16:4317\u201330.","journal-title":"J Inflamm Res"},{"key":"3636_CR45","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/apt.17063","volume":"56","author":"AR Bourgonje","year":"2022","unstructured":"Bourgonje AR, Alexdottir MS, Otten AT, Loveikyte R, Bay-Jensen AC, Pehrsson M, et al. Serological biomarkers of type I, III and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohn\u2019s disease. Aliment Pharm Ther. 2022;56:675\u201393.","journal-title":"Aliment Pharm Ther"},{"key":"3636_CR46","doi-asserted-by":"publisher","first-page":"3790","DOI":"10.1038\/s41388-018-0242-z","volume":"37","author":"G Vaniotis","year":"2018","unstructured":"Vaniotis G, Rayes RF, Qi S, Milette S, Wang N, Perrino S, et al. Collagen IV-conveyed signals can regulate chemokine production and promote liver metastasis. Oncogene. 2018;37:3790\u2013805.","journal-title":"Oncogene"},{"key":"3636_CR47","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41420-021-00793-6","volume":"8","author":"YZ Hu","year":"2022","unstructured":"Hu YZ, Hu ZL, Liao TY, Li Y, Pan YL. LncRNA SND1-IT1 facilitates TGF-\u03b21-induced epithelial-to-mesenchymal transition via miR-124\/COL4A1 axis in gastric cancer. Cell Death Discov. 2022;8:73.","journal-title":"Cell Death Discov"},{"key":"3636_CR48","first-page":"6387","volume":"17","author":"R Huang","year":"2018","unstructured":"Huang R, Gu W, Sun B, Gao L. Identification of COL4A1 as a potential gene conferring trastuzumab resistance in gastric cancer based on bioinformatics analysis. Mol Med Rep. 2018;17:6387\u201396.","journal-title":"Mol Med Rep"},{"key":"3636_CR49","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.matbio.2022.04.002","volume":"109","author":"SE Wilson","year":"2022","unstructured":"Wilson SE, Shiju TM, Sampaio LP, Hilgert GSL. Corneal fibroblast collagen type IV negative feedback modulation of TGF beta: A fibrosis modulating system likely active in other organs. Matrix Biol. 2022;109:162\u201372.","journal-title":"Matrix Biol"},{"key":"3636_CR50","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13287-020-02083-x","volume":"12","author":"J Zhou","year":"2021","unstructured":"Zhou J, Lin Y, Kang X, Liu Z, Zhang W, Xu F. microRNA-186 in extracellular vesicles from bone marrow mesenchymal stem cells alleviates idiopathic pulmonary fibrosis via interaction with SOX4 and DKK1. Stem Cell Res Ther. 2021;12:96.","journal-title":"Stem Cell Res Ther"},{"key":"3636_CR51","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/pin.12861","volume":"69","author":"Y Saiki","year":"2019","unstructured":"Saiki Y, Horii A. Multiple functions of S100A10, an important cancer promoter. Pathol Int. 2019;69:629\u201336.","journal-title":"Pathol Int"},{"key":"3636_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01424-6","volume":"22","author":"S Ji","year":"2024","unstructured":"Ji S, Shi Y, Yin B. Macrophage barrier in the tumor microenvironment and potential clinical applications. Cell Commun Signal. 2024;22:74.","journal-title":"Cell Commun Signal"},{"key":"3636_CR53","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/s41423-019-0278-1","volume":"17","author":"Y Lou","year":"2020","unstructured":"Lou Y, Han M, Liu H, Niu Y, Liang Y, Guo J, et al. Essential roles of S100A10 in Toll-like receptor signaling and immunity to infection. Cell Mol Immunol. 2020;17:1053\u201362.","journal-title":"Cell Mol Immunol"},{"key":"3636_CR54","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/s10238-022-00888-z","volume":"23","author":"R Qin","year":"2023","unstructured":"Qin R, Ren W, Ya G, Wang B, He J, Ren S, et al. Role of chemokines in the crosstalk between tumor and tumor-associated macrophages. Clin Exp Med. 2023;23:1359\u201373.","journal-title":"Clin Exp Med"},{"key":"3636_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108072","volume":"99","author":"YB Chu","year":"2021","unstructured":"Chu YB, Li J, Jia P, Cui J, Zhang R, Kang X, et al. Irf1- and Egr1-activated transcription plays a key role in macrophage polarization: A multiomics sequencing study with partial validation. Int Immunopharmacol. 2021;99:108072.","journal-title":"Int Immunopharmacol"},{"key":"3636_CR56","doi-asserted-by":"publisher","first-page":"e0145342","DOI":"10.1371\/journal.pone.0145342","volume":"10","author":"KA Jablonski","year":"2015","unstructured":"Jablonski KA, Amici SA, Webb LM, Ruiz-Rosado de JD, Popovich PG, Partida-Sanchez S, et al. Novel Markers to Delineate Murine M1 and M2 Macrophages. PLoS One. 2015;10:e0145342.","journal-title":"PLoS One"},{"key":"3636_CR57","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.cell.2023.02.020","volume":"186","author":"DJ Kloosterman","year":"2023","unstructured":"Kloosterman DJ, Akkari L. Macrophages at the interface of the co-evolving cancer ecosystem. Cell. 2023;186:1627\u201351.","journal-title":"Cell"},{"key":"3636_CR58","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.gpb.2021.08.001","volume":"19","author":"T Chen","year":"2021","unstructured":"Chen T, Chen X, Zhang S, Zhu J, Tang B, Wang A, et al. The Genome Sequence Archive Family: Toward Explosive Data Growth and Diverse Data Types. Genomics Proteom Bioinforma. 2021;19:578\u201383.","journal-title":"Genomics Proteom Bioinforma"},{"key":"3636_CR59","unstructured":"Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2022. Nucleic Acids Res. 2022; 50: D27-D38."}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03636-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03636-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03636-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:02:11Z","timestamp":1792515731000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03636-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,17]]},"references-count":59,"alternative-id":["3636"],"URL":"https:\/\/doi.org\/10.1038\/s41416-026-03636-2","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,17]]},"assertion":[{"value":"5 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Collection and usage of clinical and pathological specimens were approved by the Third Affiliated Hospital of Guangzhou Medical University\u2019s Ethical Committee Board (Approval number: EN-2024300). All patients provided informed consent for sample collection and use. The use of animals and all procedures were approved by the Animal Experimentation Ethics Committee of Guangzhou Medical University (S2024-009).","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}